Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Corcept Therapeutics has selected PharmaForm as its primary commercial manufacturer for FDA approved drug product, Korlym.
Subscribe to our email newsletter
The Korlym has received FDA approval for patients with endogenous Cushing’s syndrome.
PharmaForm is a full-service contract provider of development and manufacturing for the pharmaceutical and biotech industry.
PharmaForm has worked with Corcept for several years as a contract provider for services in the development, optimization and validation of the manufacturing process for Corcept’s Korlym.